Crescent City Research Consortium, LLC SC

Metairie, Louisiana 70006

0 studies enrolling now · 2 studies all time

What they study most

Metastatic Breast Cancer, Renal Cell Carcinoma

Studies at this site

• A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi — Stopped early
• Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma — Completed